ANAB — ANAPTYSBIO INC

Ownership history in CAXTON ASSOCIATES LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which CAXTON ASSOCIATES LP reported a position in ANAPTYSBIO INC (ANAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2023 Q3)
Avg. % of fund
0.03%
First filed
2023 Q3
Last filed
2024 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 ADDED 20,413 +1,222 +6.4% 0.03% $684K $33.50
2023 Q4 ADDED 19,191 +4,296 +28.8% 0.02% $411K $21.42
2023 Q3 INITIATED 14,895 — — 0.04% $268K —
% of Fund (quarterly)    ANAB price (monthly, adj. close)

Other funds also holding ANAB

As of 2025 Q4 — sorted by position size

EcoR1 Capital, LLC 3Y 7Y 17.33% Palo Alto Investors LP 3Y 7Y 4.66% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 3.19% First Light Asset Management, LLC 3Y 7Y 2.4% HighMark Wealth Management LLC 3Y 1.86% 683 Capital Management, LLC 3Y 7Y 1.37% Affinity Asset Advisors, LLC 3Y 1.23% Sofinnova Investments, Inc. 3Y 7Y 0.6% nVerses Capital, LLC 0.48% DCF Advisers, LLC 3Y 0.46%
← Back to CAXTON ASSOCIATES LP Holdings